The bacterial strain Magnetospirillum gryphiswaldense MSR-1 does not produce siderophores, but it absorbs a large amount of ferric iron and synthesizes magnetosomes. We demonstrated previously the presence of six types of ferric reductase isozymes (termed FeR1 through FeR6) in MSR-1. Of these isozymes, FeR5 was the most abundant and FeR6 showed the highest ferric reductase activity. In the present study, we cloned the fer5 and fer6 genes from MSR-1 and expressed them separately in Escherichia coli. FeR5 and FeR6 were shown to be bifunctional enzymes through analysis of amino acid sequence homologies, structural predictions (using data from GenBank), and detection of enzyme activities. FeR5 is a thioredoxin reductase and FeR6 is a flavin reductase, in addition to being ferric reductases. To elucidate the functions of the enzymes, we constructed two single-gene-deletion mutant strains (⌬fer5 and ⌬fer6 mutants) and a double-gene-deletion mutant strain (⌬fer5 ⌬fer6 [⌬fer5؉6] mutant) along with its complemented strains (C5 and C6). An evaluation of phenotypic and physiological properties did not reveal significant differences between the wild-type and single-gene-deletion strains, whereas the double-gene-deletion strain showed reduced iron absorption and no magnetosome synthesis. Complementation of the double-gene-deletion strain using either fer5 or fer6 resulted in the partial recovery of magnetosome synthesis. Quantitative real-time PCR analysis of fer5 and fer6 transcriptional levels in the wild-type and complemented strains demonstrated consistent transcription of the two genes and confirmed that FeR5 and FeR6 are bifunctional enzymes that play complementary roles during the process of magnetosome synthesis in MSR-1.
I ron, the fourth most abundant element on earth, is essential for many physiological reactions, including protein synthesis in almost all organisms. However, iron in the environment can rarely be utilized directly. Under aerobic or alkaline conditions, ferric iron (Fe 3ϩ ) is present only in the oxidized form, which is insoluble and unavailable for microorganism growth. Ferrous iron (Fe 2ϩ ) has greater solubility than Fe 3ϩ but is easily oxidized in the atmosphere and is found only in acidic or anaerobic environments (1) . Bacteria and other microorganisms have developed a variety of strategies for overcoming these difficulties and acquiring iron from the environment (2, 3) . Some of the major strategies for iron uptake used by bacteria are (i) the production and utilization of siderophores (Fe 3ϩ -specific chelators), (ii) the utilization of host iron compounds such as heme, and (iii) the reduction of Fe 3ϩ to Fe 2ϩ ("ferric reduction") and subsequent transport of Fe 2ϩ . Ferric reduction is an important process for iron uptake and release in bacteria. Ferric reductase is a key oxidoreductase that reduces Fe 3ϩ to Fe 2ϩ , with flavin mononucleotide (FMN), flavin adenine dinucleotide (FAD), or riboflavin as the cofactor and NAD(P)H as the hydrogen donor (4) .
Bifunctional enzymes contain a minimum of two active sites and usually catalyze two consecutive reactions (5) . Such enzymes are found widely in microorganisms; some examples are catalasephenol oxidase in Scytalidium thermophilum (6) , tryptophan synthase in Salmonella enterica serovar Typhimurium (7) , and acetyltransferase-uridyltransferase in Escherichia coli (8) . Bifunctional enzymes involved in ferric reduction have been found in some bacteria. Enzymes such as flavin reductases (9, 10) , lipoyl dehydrogenase, and glutathione reductase are also ferric iron reductases but are not specific only for iron (11) . Flavin reductases cata-lyze the reduction of flavins, FMN, FAD, or riboflavin by reduced pyridine nucleotides, NADPH or NADH (9) . They also reduce ferric compounds (with flavins, FMN, or FAD as the cofactor) in vitro and play important roles in bacterial iron assimilation in vivo (10) .
The Gram-negative microaerophilic bacterium Magnetospirillum gryphiswaldense MSR-1 actively takes up iron to synthesize magnetosomes, which are membrane-bound chains composed of nanometer-sized particles of magnetite (Fe 3 O 4 ) (12) . The total iron content in magnetotactic bacteria such as MSR-1 may exceed 2% of dry weight, compared to only 0.005 to 0.022% of dry weight in nonmagnetotactic bacteria such as E. coli (13) (14) (15) . Magnetotactic bacteria naturally have highly efficient mechanisms of iron uptake and transport. In one study, MSR-1 cells did not produce siderophores under either iron-deficient or iron-enriched culture conditions (16) but still displayed strong iron uptake. Rong et al. found that two Fe 2ϩ transporters (FeoAB1 and FeoAB2) play key roles in the iron uptake required for magnetosome formation in MSR-1 (17, 18) . In a study by Schüler and Baeuerlein of strain MSR-1 cultured with an extracellular iron concentration of 5 M, the initial uptake rate was low for Fe 2ϩ (0.06 nmol min Ϫ1 [mg dry weight] Ϫ1 ) and 7-fold higher for Fe 3ϩ (0.43 nmol min Ϫ1 [mg dry weight] Ϫ1 ] (16) . These findings, taken together, indicate that the reduction of Fe 3ϩ through ferric reductase is essential for magnetosome synthesis. We previously found six ferric reductase isoenzymes (termed FeR1 through FeR6) in the MSR-1 strain, of which FeR5 had more content and FeR6 had the highest ferric reduction activity level (X. Meng, unpublished data). In a comparison of ferric reductase activities in crude cellular extracts, we found that the activity of MSR-1 was much higher than that of Magnetospirillum magnetotacticum strain MS-1 (X. Meng, unpublished data).
In the present study, the properties and functions of ferric reductases in MSR-1 were analyzed in vivo and in vitro. FeR5 and FeR6 were shown to be bifunctional enzymes; FeR5 is both a thioredoxin reductase and a ferric reductase, and FeR6 is both a flavin reductase and a ferric reductase. Deletion of the gene for just one of these enzymes had no significant effects on cell growth, iron absorption capacity, or magnetosome synthesis. However, deletion of the genes for both FeR5 and FeR6 resulted in the blocking of magnetosome synthesis. Our findings indicate that FeR5 and FeR6 play complementary roles in ferric reduction and magnetosome synthesis in the MSR-1 strain.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Wild-type (WT) M. gryphiswaldense strain MSR-1 was cultured microaerobically in composite sodium lactate medium (SLM) at 30°C (18) . E. coli strain DH5␣ was cultured in Luria broth at 37°C. Sterilized ferric citrate was added as an iron source after autoclaving. The antibiotics (and concentrations) used for MSR-1 were nalidixic acid (5 g ml Ϫ1 ), kanamycin (Km) (5 g ml Ϫ1 ), chloramphenicol (Cm) (5 g ml Ϫ1 ), and gentamicin (Gm) (5 g ml Ϫ1 ). The antibiotics (and concentrations) used for DH5␣ were ampicillin (Amp) (100 g ml Ϫ1 ), Km (50 g ml Ϫ1 ), Cm (50 g ml Ϫ1 ), and Gm (5 g ml Ϫ1 ). Standard procedures were used for DNA isolation, digestion, ligation, and transformation.
Sequence alignment and structural prediction of FeR5 and FeR6. Multiple-sequence alignment was performed using the online Easy Sequencing in Postscript (ESPript) program (http://espript.ibcp.fr/ESPript /ESPript/index.php). Models of MSR-1 thioredoxin reductase and flavin reductase were generated using the MODELLER 9.1 program with the default parameters (19) .
Expression and purification of FeR5 and FeR6. The primers used in this study are listed in Table S1 in the supplemental material. The fer5 gene was obtained by PCR using the forward primer pETfer5pf, which encoded a BspHI site, and the reverse primer pETfer5pr, which contained the coding sequence up to the termination codon followed by an XhoI site. The amplified fragment was ligated to pMD19-T simple for sequencing and was then digested with BspHI-XhoI and ligated to BspHI-XhoI-digested pET28a to construct plasmid pET-fer5. The construction of plasmid pET-fer6 was similar to that of pET-fer5 except that the forward primer pETfer6pf and the reverse primer pETfer6pr were used.
Plasmids pET-fer5 and pET-fer6 were transformed separately into E. coli strain BL21(DE3) containing a lacUV promoter-driven T7 RNA polymerase. Soluble FeR5 and FeR6 were expressed and purified essentially as described previously (20, 21) . The supernatants, which contained His-FeR5 and His-FeR6, were applied separately to a nickel-nitrilotriacetic acid-agarose (Ni-NTA) column (code 70666-3; Novagen, Germany) equilibrated with buffer (50 mM Tris-HCl [pH 8.0], 300 mM NaCl, 10 mM imidazole). Proteins conjugated with Ni-NTA were eluted in a stepwise manner with 5 ml buffer containing 50, 80, 100, and 150 mM imida- (4, 22) , with trapping of the product as an Fe II -3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine (ferrozine) complex. The assay mixture contained 0.1 mM NADH, 0.2 mM ferric citrate, 1.0 M flavin mononucleotide (FMN), and 20 mM Tris-HCl buffer (pH 7.4) in a total volume of 1 ml. The reaction was initiated by the addition of the enzyme, and the increase in optical density at 562 nm (OD 562 ) was monitored spectrophotometrically at room temperature. Under these experimental conditions, nonenzymatic reduction was scarcely observed. The specific activity of ferric iron reductase was expressed as nanomoles of Fe II -ferrozine formed per minute per milligram of protein. Flavin reductase activity was determined by measuring the change in absorbance at 340 nm resulting from the oxidation of NADH and the reduction of FMN. One unit of flavin reductase activity was defined as the amount of enzyme that oxidized 1 mol NADH min Ϫ1 (23). Thioredoxin reductase activity was determined using a BioVision thioredoxin reductase assay kit (K763-100; BioVision Research, Mountain View, CA). One unit of thioredoxin reductase activity was defined as the amount of enzyme that generates 1.0 mol trinitrobenzene (TNB) min Ϫ1 at 25°C. The oxidation of 1 mol NADPH to NADP generates 2 mol TNB; thus, 1 TNB unit is equal to a 0.5 NADP unit. A reaction mixture containing all of the reaction substrates except the enzyme was used as the control. In the process of absorbance determination, the control was used as a blank.
Construction of ⌬fer5, ⌬fer6, and ⌬fer5؉6 mutant strains. An upstream region (924 bp) and a downstream region (834 bp) were amplified using the primer pairs fer5uf and fer5ur and fer5df and fer5dr (see Table  S1 in the supplemental material), respectively. A Km cassette was digested from the pUC4K vector with BamHI. These three fragments were fused by cloning them into the HindIII and SalI sites of the pSUP202 vector, yielding pSFK. The pSFK plasmid was introduced into MSR-1 through biparental conjugation and screening for Km r Cm s colonies as described previously (18) , and double crossover was confirmed by PCR. The resulting strain was termed the ⌬fer5 mutant.
A suicide plasmid (pSFG) containing the disrupted fer6 gene was constructed in a manner similar to that for pSFK using the primer pairs fer6uf and fer6ur and fer6df and fer6dr (see Table S1 in the supplemental material). The single-deletion ⌬fer6 mutant was obtained through biparental conjugation, screening, and PCR confirmation as described above.
pSFK plasmids were introduced into the ⌬fer6 mutant through biparental conjugation and screening for Km r Gm r colonies, and double crossover was confirmed by PCR. The resulting strain was termed the ⌬fer5 ⌬fer6 (⌬fer5ϩ6) mutant.
Construction of complemented strains. The primers cfer5pf and cfer5pr, containing the restriction sites for BamHI and XhoI (see Table S1 in the supplemental material), were used for fer5 gene cloning. The primers cfer6pf and cfer6pr were used for fer6 cloning. The amplified fragment was ligated to the pMD19-T simple vector (code D104A; TaKaRa Biotechnology, Dalian, China) and digested with BamHI and XhoI. The resulting BamHI-XhoI fer5 and fer6 fragments were ligated into the BamHI-XhoI sites of pPR9TT, generating pPfer5 and pPfer6, respectively.
The promoter of the kanamycin resistance gene was amplified from plasmid pUC4K as a template using the primers kanpf and kanpr. The fragment was ligated into the BamHI-SacI sites of pPfer5 and pPfer6, generating pPfer5k and pPfer6k. pPfer5k and pPfer6k were introduced into the ⌬fer5ϩ6 mutant through biparental conjugation, and transconjugants were screened for Gm r Cm r colonies. The presence of intact fer5 or fer6 was confirmed by PCR. The single-gene (fer5 or fer6) complemented strains of ⌬fer5ϩ6 mutants were termed C5 and C6, respectively.
Cell growth and magnetic response curves of mutants and complemented strains. All strains were grown synchronously in SLM at 30°C for 34 h. The OD 595 was measured using a UV-visible spectrophotometer (UNICO2100; UNICO Instrument Co., Shanghai, China). The coefficient of magnetism (C mag ) values were calculated from measurements of the maximal and minimal scattering intensities. OD 595 and C mag values were measured every 2 h and were used to construct OD 595 and C mag curves. The C mag values were generally correlated with the average magnetosome numbers, and these parameters showed a nearly linear correlation at low magnetosome numbers (24) .
Iron content of cells. Iron content was determined in triplicate assays as described previously (18, 25) . Each strain was cultured microaerobically at 30°C in SLM containing 0, 5, 20, 50, or 80 M ferric citrate. After reaching the stationary phase, cells were harvested by centrifugation and washed three times with 20 mM Tris-HCl (pH 7.4). The pellets were dried to constant weight and nitrified in 1 ml nitric acid for 3 h. The iron content was assayed using an atomic absorption spectrometer (Optima 5300DV; PerkinElmer, Waltham, MA).
TEM. Each strain was grown in SLM at 30°C until it reached the stationary phase and then was concentrated from suspension by centrifugation (12,000 rpm, 1 min). Cells was adsorbed onto carbon-coated copper grids and rinsed twice with double-distilled H 2 O. Samples were observed with conventional transmission electron microscopy (TEM) (Tecnai F30; Philips, Eindhoven, Netherlands) at 120 kV and high-resolution TEM (JEOL2010; Jeol, Tokyo, Japan) at 200 kV. For each sample, 40 to 45 randomly chosen cells were examined. The crystal parameters (e.g., crystal size of magnetosomes and shape factors) were estimated from digitized TEM micrographs using the ImageJ 1.36b program (http://rsbweb.nih .gov/ij).
qPCR. RNA was extracted from cells using an ultra-pure RNA rapid extraction kit (Biomed Corp., London, United Kingdom) according to the manufacturer's instructions, with some modifications; for better extraction, a bacterial sludge was created by adding liquid nitrogen and grinding the mixture into powder prior to the addition of the lysis buffer (26) (27) (28) (29) . The mRNA transcripts were quantified by quantitative real-time PCR (qPCR). Primers (Invitrogen Corp., Beijing, China), RNA polymerase ␤ subunit(rpoC) (EBI locus tag MGR_3807) as a reference gene, and fer5 and fer6 as target genes were designed using the DNAman program (see Table S2 in the supplemental material). qPCR was performed using a SYBR green I master kit with a LightCycler 480 qPCR instrument (Roche, South San Francisco, CA). For transcript detection, SYBR green I was added to a standard PCR mix, using 2 reaction volumes, as described previously (26) . qPCR runs were performed on a CFX 96 instrument (Bio-Rad, Hercules, CA) using the cycle parameters listed in Tables S3 and  S4 in the supplemental material. The fer5 and fer6 gene transcription levels were determined using the threshold cycle (⌬C T ) method, a variation of the Livak method where ⌬C T ϭ C T (reference gene) Ϫ C T (target gene) (27) . The data analysis was based on three independent experiments.
RESULTS

Amino acid sequences and structural prediction of FeR5 and
FeR6 proteins. The fer5 gene of MSR-1 (EBI locus tag MGR_2378) was composed of 951 bp and encoded 316 amino acid residues. The FeR5 protein was defined as a thioredoxin reductase (EMBL accession no. CAM75562) and showed 83.5% identity with a thioredoxin reductase from Magnetospirillum magneticum AMB-1 (NCBI accession no. YP_420026). Some thioredoxin reductases from nonmagnetic bacteria were found in GenBank, each of which had Ͼ50% identity with FeR5. Among these, a thioredoxin reductase from E. coli (Protein Data Bank [PDB] identification no. 1TDF) with 55% identity with FeR5 was taken as a representative. The amino acid sequences of no. YP_420026, no. 1TDF, and FeR5 are compared in Fig. 1A (the conserved amino acid residues are indicated by red boxes). The predicted protein structure is shown in Fig. S1A in the supplemental material, with the NAD binding region (blue) and FAD binding region (orange) of FeR5 (green) and no. 1TDF (cyan) in the simulation of the tertiary structure. We found previously that FeR5 has ferric reductase activity; therefore, we propose that it is a bifunctional enzyme in the MSR-1 strain.
The fer6 gene (EBI locus tag MGR_3067) was composed of 489 bp and encoded 162 amino acid residues. The FeR6 protein was classified as "flavin reductase-like, FMN-binding" (EMBL accession no. CAM76714). Amino acid sequence BLAST analysis of FeR6 showed 62.9% identity with an actinorhodin polyketide di-merase from M. magneticum AMB-1 (NCBI accession no. YP_421940). Amino acids 12 to 155 of no. YP_421940 were annotated as a "flavin reductase-like domain." Fifteen flavin reductases from nonmagnetic bacteria were found in GenBank, each of which had Ͼ40% identity with FeR6. One crystal of a flavin reductase from Burkholderia cepacia strain AC1100 (PDB identification no. 3K88) was analyzed (30) . This protein showed 33% Superpositions of the FMN or FAD (orange) and NAD (blue) binding domains of FeR6 (green) and no. 3K88 (cyan) are shown in Fig. S1B in the supplemental material. In view of the ferric reductase activity of FeR6, we propose that it is also a bifunctional enzyme in strain MSR-1.
Enzyme activities of FeR5 and FeR6. For the purification and characterization of FeR5 and FeR6, we constructed the expression plasmids pET-fer5 and pET-fer6 and expressed them in E. coli strain BL21(DE3). Upon induction with isopropyl-␤-D-thiogalactopyranoside (IPTG), fusion proteins were expressed by E. coli. A series of enzyme activity measurements were performed using purified His-FeR5 and His-FeR6 ( Fig. 2A and B ). His-FeR5 had a ferric reductase activity of 1,410 nmol · min Ϫ1 · mg Ϫ1 and a thioredoxin reductase activity of 66.15 nmol · min Ϫ1 · ml Ϫ1 , while His-FeR6 had a ferric reductase activity of 1,792 nmol · min Ϫ1 · mg Ϫ1 and a flavin reductase activity of 120.46 nmol · min Ϫ1 · mg Ϫ1 ( Table 2 ). The ferric reductase activity of purified FeR5 was slightly lower than that of FeR6. Although the heterologous expression of ferric reductase activity was lower than the activity of FeR6 (natural enzyme) purified from the WT strain (31) , it is clear that both proteins are bifunctional enzymes.
Cell growth and magnetic responses. To study the functions of FeR5 and FeR6, we constructed single-gene-deletion strains (⌬fer5 and ⌬fer6 mutants), a double-gene-deletion strain (⌬fer5ϩ6 mutant), and its complemented strains (C5 and C6) as described in Materials and Methods. All strains were verified by PCR and then evaluated for cell growth and magnetic responses.
Cells of each strain were cultured in SLM until they reached the stationary phase. OD 595 and C mag values were recorded at defined times and used to draw growth curves. The ⌬fer5 and ⌬fer6 mutants showed no significant difference in growth status from the WT, while the ⌬fer5ϩ6 mutant and the complemented strains showed a slight lag at the logarithmic stage (see Fig. S2A and B in the supplemental material). The C mag values for the WT, ⌬fer5 mutant, and ⌬fer6 mutant showed a consistent trend with each other (see Fig. S3A in the supplemental material), whereas the ⌬fer5ϩ6 mutant showed C mag values of 0 (see Fig. S3B in the supplemental material). The C5 and C6 strains showed partial recovery of magnetic responses.
These findings indicate that the single-gene deletions did not affect cell growth or magnetic responses, whereas the double-gene deletion caused a reduction in cell growth and a magnetic response of 0. Complementation of the double-gene-deletion strain with either fer5 or fer6 had essentially the same effects, indicating that the two proteins have complementary roles.
Intracellular iron content. The strains were cultured in media containing various iron concentrations, and cells were then treated with nitric acid and filtered for measurement of intracellular iron content using an atomic absorption spectrometer. For the treatments with 0 M or 5 M ferric citrate, no significant differences in intracellular iron content were observed among the WT, ⌬fer5, ⌬fer6, ⌬fer5ϩ6, and complemented strains ( Table 3) . With the 20 M ferric citrate treatment, the iron content was roughly the same in the WT and the single-gene-deletion strains and was 2.8 times higher than in the double-gene-deletion strain, 1.6 times higher than in C5, and 1.5 times higher than in C6. With the 50 M ferric citrate treatment, the iron content of the WT was 1.2 times higher than in the ⌬fer5 and ⌬fer6 mutants, 3.5 times higher than in the ⌬fer5ϩ6 mutant, 1.6 times higher than in C5, and 1.1 times higher than in C6. With the 80 M ferric citrate treatment, the iron content of the WT was 1.3 times higher than in the ⌬fer6 mutant, 4.9 times higher than in the ⌬fer5ϩ6 mutant, 1.3 times higher than in C5, and 1.6 times higher than in C6.
These findings indicate that low external concentrations (0 to 5 M) of iron did not result in differences in iron absorption among the various strains. An external supply of 20 M Fe 3ϩ was sufficient for magnetosome synthesis. When the external iron concentration was increased to 50 M, the Fe 3ϩ absorption capacity of the WT was greater than that of the other strains. With a high concentration of Fe 3ϩ , the iron absorption capacity of the singlegene-deletion strains was slightly affected. When the external iron concentration was increased to 80 M, the absorption capacity of WT cells reached its saturation level, and the intracellular iron content could not increase further. It appears that the gene activities of fer5 and fer6 have a close relationship with ferric iron absorption. The iron absorption capacity was lower in the singlegene-deletion strains and complemented strains. The addition of 20 M Fe 3ϩ was sufficient for normal magnetosome synthesis. Higher Fe 3ϩ concentrations (50 M and 80 M) did not significantly increase the intracellular iron content in gene deletion or complemented strains. The double-gene-deletion ⌬fer5ϩ6 strain maintained cell growth and reproduction when a trace amount of Fe 3ϩ was present but lost the ability to form magnetosomes.
Magnetosome formation ability. Our preliminary experiments showed that a 20 M iron source was sufficient for magne- tosome synthesis in cultured cells. Therefore, TEM and high-resolution TEM observations were performed with cells cultured with a 20 M iron source. In Fig. 3 , comparisons of cells (left column), magnetosome chains (middle column), and magnetosome crystal lattices (right column) of the WT, ⌬fer5, ⌬fer6, C5, and C6 strains are shown. No magnetosomes were formed by the double-gene-deletion ⌬fer5ϩ6 strain (Fig. 4) .
The WT, single-gene-deletion, and complemented strains all synthesized magnetosomes (Fig. 3, left and middle columns) . The crystal lattices revealed the presence of standard Fe 3 O 4 crystals (right column) regardless of the size of the magnetosome, indicating that the magnetosomes were mature. In C5 and C6, the magnetosome chains were shorter but the crystals had matured.
The average numbers and diameters of magnetosomes in the various strains, based on TEM observations, are shown in Table 4 . The average numbers for the single-gene-deletion and complemented strains were similar to those for the WT. The percentages of cells having 6 to 10 magnetosomes for the ⌬fer5 mutant, the ⌬fer6 mutant, C5, and C6 were 48%, 43%, 43%, and 46%, respectively. The proportion of single cells containing Ͼ10 magnetosomes, relative to the total cell number, was slightly higher for the WT than for the other strains. The average magnetosome number ranged from 8.9 Ϯ 4.6 to 10.5 Ϯ 4.8, and the average magnetosome diameter ranged from 25.3 Ϯ 12.7 to 33.2 Ϯ 5.3 nm. Neither of these parameters showed significant differences among the WT, single-gene-deletion, and complemented strains. The ability to synthesize magnetosomes was restored in C5 and C6, indicating that either FeR5 or FeR6 is partially complementary in the doublegene-deletion strain.
When the fer5 and fer6 genes were deleted, the ability to synthesize magnetosomes was lost, indicating that the FeR5 or the FeR6 protein is essential for magnetosome formation. If one of the genes is disrupted, then another gene function plays a complementary role.
Transcriptional levels of fer5 and fer6. When a particular gene is suppressed in a cell, the expression of another gene is often increased to compensate; two such genes have complementary functions. Transcriptional levels of fer6 in WT, ⌬fer5, and C6 cells after 6, 12, 18, and 24 h of culture are shown in Fig. 5A . The transcriptional levels in the ⌬fer5 mutant and C6 were Ͼ2.5-fold higher than in the WT at 6 h and ϳ1.5-fold higher at 12 h but fell below the WT level by 18 h. These findings indicate that fer6 was highly expressed in the early growth of the ⌬fer5 mutant and C6 and was thereby complementary to fer5 deletion. Thus, fer6 participated in ferric reduction, the absorption process for biomineralization during the early stage of cell growth, and remission of cellular metabolism injury when fer5 was deleted. qPCR results for fer5 transcriptional levels in WT, ⌬fer6, and C5 cells at various times are shown in Fig. 5B . At 6 h, the levels for the ⌬fer6 mutant and C5 were 1.95-fold and 1.78-fold higher, respectively, than for the WT. The level for the ⌬fer6 mutant was one-half that of the WT at 12 h, and that of C5 was similar to that of the WT at 12 h. The ⌬fer6 mutant and C5 apparently complemented the fer6 gene function by upregulating fer5 transcriptional levels. fer5 was highly expressed during the growth period from 12 to 24 h and contributed to the process of magnetosome synthesis.
The transcriptional levels for fer5 and fer6 in the WT were slightly different. The level for fer5 was high throughout the period of magnetosome synthesis, while the level for fer6 was lower. The two proteins clearly have complementary functions, as confirmed by observations of the single-gene-deletion and complemented strains.
DISCUSSION
Two bifunctional enzymes involved in ferric reduction in M. gryphiswaldense strain MSR-1. In this study, we analyzed the characteristics and functions of the FeR5 and FeR6 proteins in iron metabolism and magnetosome formation in MSR-1. Protein sequence and three-dimensional structural analysis indicated that FeR5 had high sequence and structural homology to thioredoxin reductase in bacteria. There were conserved FAD (or FMN) and NAD binding domains. FeR5 also contained a conserved disulfide redox active site (Ala-Cys-Ala-Thr-Cys-Asp) identical to that in E. coli thioredoxin reductase (32) . Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that FeR5 participated in the selenocompound and pyridine nucleotide metabolic pathways. In these pathways, FeR5 was designated EC 1.8.1.9 and named thioredoxin-disulfide reductase or NADP(H)-thioredoxin reductase. Prokaryotic thioredoxin reductase belongs to the pyridine nucleotide-disulfide oxidoreductase family of flavoenzymes; this family also includes lipoamide dehydrogenase, glutathione reductase, mercury reductase, and NADH peroxidase (33) . Petrat et al. found that the NAD(P)H-dependent flavoenzymes lipoyl dehydrogenase (EC 1.8.1.4) and glutathione reductase (EC 1.6.4.2) ef-fectively catalyzed the one-electron reduction of Fe 3ϩ complexes of citrate, ATP, and ADP at the expense of the coenzyme NA-D(P)H (11) . Fe 3ϩ reduction was presumably mediated by reduced flavin provided by electron transfer from NAD(P)H to FAD. Petrat et al. proposed that the enzymes involved in the reduction of intracellular or extracellular ferric chelates belong to the family of pyridine nucleotide-disulfide oxidoreductase classes I and II (e.g., glutathione reductase and thioredoxin reductase) (11) . We demonstrated through enzyme activity determination that FeR5, designated a thioredoxin reductase in strain MSR-1, is responsible for Fe 3ϩ and thioredoxin reduction. FeR5 (EC 1.8.1.9) is close to lipoyl dehydrogenase (EC 1.8.1.4) in enzymatic classification status. Both of these enzymes are oxidoreductases with a thiol group as the donor and NAD(P) ϩ as the acceptor. We therefore presume that the Fe 3ϩ reduction mechanism of FeR5 is similar to that of lipoyl dehydrogenase. A thioredoxin reductase-like protein from Thermos scotoductus SA-01 that occurs in pairs, rather than singly, also displayed high iron reductase activity. This protein was regarded as a ferric reductase. It shared high sequence and structural similarity with prokaryotic thioredoxin reductases but lacked the disulfide redox active site (33) . These findings all indicate that FeR5 is a true thioredoxin reductase and is bifunctional, i.e., displays a dual function to reduce Fe 3ϩ and thioredoxin in vitro.
FeR6 is another ferric reductase isozyme that we purified previously (31) . Enzyme activity determination indicated that FeR6 was more effective than FeR5 in Fe 3ϩ reduction. A FeR6 protein sequence obtained through bioinformatics analysis showed high homology with flavin reductases from certain bacteria. Three-dimensional structural prediction showed that the FeR6 structure had high homology with a flavin reductase from B. cepacia, including a flavin reductase domain and a FAD (FMN) binding domain that are generally found in bacterial flavin reductases. Enzyme activity determination also confirmed that FeR6 could reduce FMN with NADH as the electron donor. Thus, FeR6 is presumably a flavin reductase in strain MSR-1.
However, we also found that a ferric complex binding site (involving Thr-36, Leu-43, Cys-53, and His-129) in FeR6 is similar to that of a true ferric reductase in Archaeoglobus fulgidus (34) . This site was recently shown to be a plausible site for Fe 3ϩ binding (35) . The enzyme activity determination showed that FeR6 could reduce ferric citrate without FMN as a cofactor in the reaction mixture. The specific activity with FMN in the reaction mixture was ϳ20-fold higher than that without FMN (data not shown); i.e., FeR6 could directly reduce Fe 3ϩ , but FMN played an important role as a cofactor. We conclude from the above findings that FeR6 is a ferric reductase that has high homology with flavin reductase. It is another bifunctional enzyme in strain MSR-1 that displays dual functions in reducing ferric compounds and flavins.
Some ferric reductases purified from bacteria were eventu- ally shown to be flavin reductases on the basis of such dual enzyme activities (10, 31) . For example, the ArsH protein from Acidithiobacillus ferrooxidans, which was originally classified as a NADPH-dependent FMN reductase, displayed high levels of ferric reductase activity in vitro (36) . The only true ferric reductase in bacteria discovered to date was identified by crystal structure analysis in the hyperthermophilic archaeon Archaeoglobus fulgidus (34) . Interestingly, this ferric reductase also displayed flavin reductase activity. The crystal structure of flavoredoxin from Desulfovibrio vulgaris strain Miyazaki F was recently determined, and the ferric reductase activity of the enzyme was examined. The flavoredoxin was found to share an overall structure with A. fulgidus ferric reductase and to display weak ferric reductase and flavin reductase activities (35) . Like flavin reductase, the NAD(P)H-dependent flavoenzyme lipoyl dehydrogenase can effectively catalyze the one-electron reduction of Fe 3ϩ complexes of citrate, ATP, and ADP at the expense of the coenzyme NAD(P)H. Glutathione reductase, cytochrome c reductase, and cytochrome P450 reductase are other flavoenzymes that can enzymatically reduce these Fe 3ϩ complexes with somewhat lower efficiency (11) . Although the above-mentioned ferric reduction enzymes are not true ferric The other four isozymes of MSR-1 ferric reductase have not been purified to date, and we did not find true ferric reductase genes through MSR-1 genome searching. We speculate that the other four ferric reductase isozymes are also oxidoreductases and may be bifunctional or multifunctional enzymes in strain MSR-1. Further studies along this line are in progress.
Complementary roles of two ferric reductases during magnetosome synthesis in strain MSR-1. To investigate the functions of the bifunctional enzymes FeR5 and FeR6 in iron uptake and magnetosome formation, we constructed ⌬fer5, ⌬fer6, and ⌬fer5ϩ6 deletion mutant strains and complemented strains C5 and C6, as described in Materials and Methods, and made phenotypic comparisons between these mutants and the WT strain. TEM observations showed that magnetosome number and crystal size in the ⌬fer5 and ⌬fer6 single-gene-deletion mutants, C5, and C6 were similar to those in the WT, whereas no magnetosomes were present in the ⌬fer5ϩ6 double-gene-deletion mutant. Single-gene deletion did not affect iron uptake, whereas deletion of both fer5 and fer6 resulted in decreased intracellular iron content. These findings indicate that fer5 and fer6 were essential for magnetosome synthesis and played an important role in iron uptake. We therefore hypothesized that FeR5 and FeR6 are the predominant ferric reductases in strain MSR-1. The WT cannot secrete siderophores to the extracellular environment but is able to take up iron by reducing Fe 3ϩ to Fe 2ϩ and then can participate in magnetosome biomineralization. Because double-gene deletion of both fer5 and fer6 but not single-gene deletion affected iron uptake, we hypothesized that the knockout of fer5 would be compensated for (complemented) by increased expression of fer6. Conversely, knockout of fer6 would be complemented by increased expression of fer5. The results of TEM observations were supported by C mag value determinations. The C mag values for the ⌬fer5 and ⌬fer6 mutants were similar to that for the WT, while that for the ⌬fer5ϩ6 mutant was close to 0. The C mag values for C5 and C6 were similar to those for the single-gene-deletion mutants. Our conclusion is further supported by qPCR analysis of fer5 and fer6 transcriptional levels. The levels of both fer6 in the ⌬fer5 mutant and fer5 in the ⌬fer6 mutant in the early log phase of growth were higher than those in the WT, indicating complementary functions of fer5 and fer6. The fer5 and fer6 levels were increased during the period of magnetosome synthesis, particularly the primary stage. We conclude that Fe 3ϩ was reduced to Fe 2ϩ by FeR5 and FeR6 for the purpose of magnetosome synthesis. The fer5 gene was transcribed throughout the growth stages, particularly during magnetosome synthesis. These findings, in combination with FeR5 enzyme activity determinations, suggest that FeR5 acted as a thioredoxin reductase as part of pyridine nucleotide metabolism during the early growth stage. When magnetosome formation began, FeR5 acted as both a thioredoxin reductase and a ferric reductase to participate in iron metabolism and pyridine nucleotide metabolism. In contrast, fer6 showed a high transcriptional level in the early stage of magnetosome formation and lower levels at later stages of cell growth. The fer6 levels corresponded to the degree of Fe 3ϩ absorption in the early growth stage.
In subsequent experiments, we confirmed by Western blotting that FeR5 and FeR6 are located in the cell membrane and magnetosome membrane. This finding indicates that the reduction of Fe 3ϩ by ferric reductase is essential for iron uptake and magneto-some synthesis in strain MSR-1. We can speculate that, when MSR-1 cells are provided with a Fe 3ϩ source, Fe 3ϩ is reduced to Fe 2ϩ by ferric reductase, Fe 2ϩ enters the cell through a cytoplasmic membrane channel, and it then participates in the steps of the biomineralization process. Further studies are needed to provide direct evidence of iron uptake in MSR-1.
In summary, we isolated and characterized two bifunctional enzymes, FeR5 and FeR6, in strain MSR-1. These two enzymes displayed thioredoxin reductase and flavin reductase activities, respectively, and both were able to reduce Fe 3ϩ to Fe 2ϩ in vitro. FeR5 and FeR6 are primarily ferric reductases and participate in magnetosome formation. If one of them was deleted, then the other displayed a complementation role in iron uptake and biomineralization. Thus, both FeR5 and FeR6 display roles in catalytic redox reactions and ferric reduction (Fe 3ϩ to Fe 2ϩ ) in M. gryphiswaldense strain MSR-1.
